Insider Actions for Deciphera Pharmaceuticals Inc.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 10/03/2022 |
Matthew L. Sherman EVP & Chief Medical Officer |
2,587 | Disposition at $18.73 per share. | 48,454 |
| 06/16/2022 |
Daniel L. Flynn Chief Scientific Officer |
1,768 | Disposition at $10.75 per share. | 19,006 |
| 06/16/2022 |
Matthew L. Sherman EVP & Chief Medical Officer |
1,768 | Disposition at $10.75 per share. | 19,006 |
| 06/16/2022 |
Daniel C. Martin Chief Commercial Officer |
1,311 | Disposition at $10.75 per share. | 14,093 |
| 06/16/2022 |
Thomas P. Kelly Chief Financial Officer |
1,768 | Disposition at $10.75 per share. | 19,006 |
| 06/16/2022 |
Jama Pitman See Remarks |
1,298 | Disposition at $10.75 per share. | 13,953 |
| 04/29/2022 |
Brightstar Associates LLC |
1,478,978 | Acquisition at $10 per share. | 14,789,780 |
| 03/21/2022 |
Steven L. Hoerter President and CEO; Director |
3,150 | Derivative/Non-derivative trans. at $9.11 per share. | 28,696 |
| 02/16/2022 |
Daniel L. Flynn Chief Scientific Officer |
1,366 | Disposition at $9.05 per share. | 12,362 |
| 02/16/2022 |
Matthew L. Sherman EVP & Chief Medical Officer |
984 | Disposition at $9.05 per share. | 8,905 |
| 02/16/2022 |
Daniel C. Martin Chief Commercial Officer |
1,146 | Disposition at $9.05 per share. | 10,371 |
| 02/16/2022 |
Thomas P. Kelly Chief Financial Officer |
1,368 | Disposition at $9.05 per share. | 12,380 |
| 02/16/2022 |
Jama Pitman See Remarks |
1,146 | Disposition at $9.05 per share. | 10,371 |
| 01/18/2022 |
Daniel L. Flynn Chief Scientific Officer |
20,500 | Award at $0 per share. | 0 |
| 01/18/2022 |
Matthew L. Sherman EVP & Chief Medical Officer |
20,500 | Award at $0 per share. | 0 |
| 01/18/2022 |
Daniel C. Martin Chief Commercial Officer |
13,667 | Award at $0 per share. | 0 |
| 01/18/2022 |
Thomas P. Kelly Chief Financial Officer |
20,500 | Award at $0 per share. | 0 |
| 01/18/2022 |
Jama Pitman See Remarks |
13,667 | Award at $0 per share. | 0 |
| 12/15/2021 |
Daniel L. Flynn Chief Scientific Officer |
11,100 | Award at $0 per share. | 0 |
| 12/15/2021 |
Matthew L. Sherman EVP & Chief Medical Officer |
11,100 | Award at $0 per share. | 0 |
| 12/15/2021 |
Daniel C. Martin Chief Commercial Officer |
8,300 | Award at $0 per share. | 0 |
| 12/15/2021 |
Thomas P. Kelly Chief Financial Officer |
11,100 | Award at $0 per share. | 0 |
| 12/15/2021 |
Jama Pitman See Remarks |
8,300 | Award at $0 per share. | 0 |
| 10/04/2021 |
Matthew L. Sherman EVP & Chief Medical Officer |
2,659 | Disposition at $33.17 per share. | 88,199 |
| 05/03/2021 |
Michael D. Taylor Director |
300 | Disposition at $46.75 per share. | 14,025 |
| 05/03/2021 |
Michael D. Taylor Director |
7,700 | Disposition at $46.07 per share. | 354,739 |
| 05/03/2021 |
Michael D. Taylor Director |
5,646 | Derivative/Non-derivative trans. at $3.95 per share. | 22,301 |
| 05/03/2021 |
Michael D. Taylor Director |
2,354 | Derivative/Non-derivative trans. at $1.89 per share. | 4,449 |
| 04/20/2021 |
James A. Bristol Director |
1,700 | Disposition at $45.6 per share. | 77,520 |
| 04/20/2021 |
James A. Bristol Director |
1,700 | Derivative/Non-derivative trans. at $3.95 per share. | 6,715 |
